Eli Lilly exploring spinoff of Elanco

Source: Market Watch Eli Lilly & Co. said Tuesday it could spin off or sell its animal health business, a segment that contributed 15% of...

Elanco, Innventure Announce Animal Health R&D Agreement

Source: Innventure news release Innventure and Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), announced a strategic initiative to explore the...

New Pipestone Disinfectant Product Shows Promise

Cleaning and disinfecting transport trailers, farrowing stalls, and pens in nursery and wean-to-finish barns has been proven critical to keeping animals healthy and preventing...

New 5-Quart Presentation of Triamulox™ Liquid Concentrate Eases Medication Storage, Handling for Pork...

Economical Solution for Managing Pneumonia, Dysentery A water-soluble antibiotic used widely in the pork industry to treat herds for respiratory and enteric disease is now...

SDSU Animal Science Department Presents Research at Midwest Section Animal Science Meeting

South Dakota State University swine researchers from the Department of Animal Science will present seven research abstracts at the Midwest Section meeting of the...

Keep guard up for strep, parasuis in newly weaned pigs

Read more articles on Pig Health Today https://pighealthtoday.com/ Newly weaned pigs face many challenges — new environment, feed, pen mates. They also face the challenge of...

Hipra Canada Launches New Swine Vaccine Vepured®

The Banff Pork Seminar is the reference meeting for the pork industry in Canada. The conference was held in Banff on January 8-10, 2019....

PED Elimination Expected by Spring

Farmscape for March 8, 2018 Full Interview 7:16 Listen Manitoba Pork says, if efforts to eliminate a Porcine Epidemic Diarrhea outbreak in southeastern Manitoba...

Merck Animal Health Hosts Animal Welfare Symposium

Newly Formed Veterinary and Consumer Affairs Group Assembles Thought Leaders to Address “Advancing Animal Welfare Together” Merck Animal Health (known as MSD Animal Health outside the...

Aptimmune Completes $6 Million Series B Funding, Moves Headquarters & Lab to St. Louis

Aptimmune Biologics announces it has completed its Series B funding initiative, raising more than $6 million from several investors. This increases the combined total...
Translate Web in Your Language »